Price by Quantity
Sanofi Dupixent (Dupilumab) Injection is a biologic medication used to treat conditions like moderate-to-severe eczema (atopic dermatitis), asthma, and chronic sinusitis with nasal polyps. It works by targeting specific immune pathways to reduce inflammation and improve symptoms.
Disclaimer: This injection should only be administered under specialist supervision. Possible side effects include injection site reactions, eye problems, or allergic responses. Regular follow-up with a healthcare provider is essential.
| Minimum Order | 10 |
| Generic Name | Dupilumab |
| Drug Class | Monoclonal Antibody |
| Brand Name | Dupixent |
| Dosage Form | Prefilled Syringe / Pen |
| Pharmacological Class | IL-4 / IL-13 Inhibitor |
| Concentration | 150 Mg/mL |
| Mechanism Of Action | Interleukin-4 Receptor Alpha (IL-4Rα) |
| Formulation Type | Sterile, Preservative-free |
| Administration | Subcutaneous Injection Only |
| Dosing Frequency | Every 2–4 Weeks |
| Biological Type | Recombinant Human Antibody |
| Shelf Stability | Limited Outside Fridge |
| Serious Risks | Hypersensitivity, Eosinophilia |
| Regulatory Approval | FDA & EMA Approved |
| Storage Condition | Refrigerated (2–8°C) |
| Manufacture By | Health Point Pharmacy |
| Origin | India |
